Literature DB >> 13303119

Novobiocin: a laboratory investigation.

G LUBASH, J VAN DER MEULEN, C BERNTSEN, R TOMPSETT.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS

Mesh：

Substances：

Year:  1956        PMID： 13303119

Source DB:  PubMed          Journal:  Antibiotic Med Clin Ther (New York)        ISSN： 0570-3107


× No keyword cloud information.
  3 in total

1.  Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates.

Authors:  E G Arathoon; J R Hamilton; C E Hench; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

2.  Effect of novobiocin and its combination with tetracycline, chloramphenicol, erythromycin, and lincomycin on the microbial generation of Escherichia coli.

Authors:  E R Garrett; C M Won
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

3.  Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.

Authors:  T J Walsh; H C Standiford; A C Reboli; J F John; M E Mulligan; B S Ribner; J Z Montgomerie; M B Goetz; C G Mayhall; D Rimland
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.